Methicillin-resistant Staphylococcus aureus-associated dermatitis in a Congo African grey parrot (Psittacus erithacus erithacus).

A 2-year-old DNA-sexed female Congo African grey parrot (Psittacus erithacus erithacus) was evaluated for self-trauma of the feathers and skin of the tail base for a duration of more than 1 year. All rectrices and tail coverts were missing, the skin of the tail base was thickened and ulcerated, and the uropygial gland was swollen. Results of a complete blood cell count revealed relative monocytosis and basophilia. Survey radiographs showed truncation and lysis of the caudal vertebrae and pygostyle. Results of biopsy and bacterial culture of the tail base lesions revealed an ulcerative bacterial dermatitis positive for staphylococcal cassette chromosome mec (SCCmec) type IV (community-acquired) methicillin-resistant Staphylococcus aureus (MRSA). The bird was treated with oral trimethoprim-sulfamethoxazole, meloxicam, fluoxetine, topical lidocaine gel, and hydrotherapy. One month later, tail feather regrowth was evident; however, follow-up over 2 years found continued self-trauma to the rectrices in spite of repeated skin biopsies negative for MRSA or other bacteria. It is unknown if the MRSA cultured from this bird was commensal or acquired from either the environment or humans to which the bird was exposed.

Infiltrative lipoma in a blue-crowned conure (Aratinga acuticaudata).

A 14-year-old blue-crowned conure (Aratinga acuticaudata) of unknown sex was brought to the hospital with a 3-week history of straining and vocalizing during defecation. Physical examination revealed blood and urate staining on feathers around the cloaca. A 2.5-cm subcutaneous swelling was palpated along the midline of the caudoventral abdomen. During surgical exploratory, a subcutaneous soft-tissue mass was found, which extended through the body wall musculature and into the coelomic cavity. The abnormal tissue was adhered to the cloacal serosa, causing deviation of the cloaca caudally and ventrally. The mass was excised and submitted for histopathology, and the histopathologic diagnosis was infiltrative lipoma. The surgical incision healed uneventfully, and no evidence of tumor regrowth was apparent 7 months after surgery. This is the first documented case of infiltrative lipoma in a bird.

Six-month prophylactic efficacy of moxidectin sustained release (SR) injectable for dogs against experimental heartworm infection in growing puppies.

The purpose of this study was to assess the efficacy of moxidectin sustained release injectable for dogs (moxidectin SR, Fort Dodge Animal Health) in protecting growing puppies from experimental infection with the heartworm, Dirofilaria immitis, six months after treatment. The study involved 27 puppies, approximately 12 weeks of age at the beginning of the study, with nine puppies in each of three size classes. The small breed class included eight Pekingese and one purpose-bred small breed mongrel; the medium breed class included nine purpose-bred mongrels, and the large breed class included nine puppies with an anticipated adult weight >or=30-35 kg. Both genders were included with no attempt made to have equal numbers of male and female puppies. Puppies were blocked by weight within each size class and randomly assigned to three treatment groups of nine dogs. On Day 0, pups in two groups were injected subcutaneously with moxidectin SR, dosed to deliver 0.17 mg moxidectin/kg b.w. The third group was injected with sterile saline. Personnel making observations were blinded to the treatment status of the animals. Following treatment, puppies were observed for signs of adverse local and systemic reactions. Puppy weights and serum moxidectin levels were also monitored. On Day 180, puppies in all treatment groups were inoculated subcutaneously with 50 third-stage larvae of D. immitis. On Days 348 and 349, puppies were euthanatized and necropsied. Hearts and lungs were examined for adult heartworms. All animals in the saline control group were infected with an arithmetic mean of 39.22 adult heartworms each. Seventeen of 18 dogs in the moxidectin SR-treated groups were uninfected. One treated puppy was infected with a single adult heartworm. This infected individual was from the large breed size class and had the second highest percent increase in body weight. Based on arithmetic means, the heartworm recovery from all treated puppies represents a 99.86% reduction relative to the saline control. There were no adverse local or systemic reactions to treatment in any animal.

Liposarcomas in dogs: 56 cases (1989-2000).

OBJECTIVE: To determine the biological behavior of liposarcomas in dogs and identify clinical signs, the effect of treatment on survival time, and potential prognostic factors. DESIGN: Retrospective study. ANIMALS: 56 dogs with histologically confirmed liposarcoma. PROCEDURE: Information was obtained on signalment, tumor size, location of the tumor, stage of disease, remission duration, overall survival time, cause of death, type of surgery (incisional biopsy, marginal excision, or wide excision), and any additional treatments given. RESULTS: Surgery consisted of incisional biopsy in 6 dogs, marginal excision in 34, and wide excision in 16. Twenty-five dogs had histologic evidence of tumor cells at the surgical margins and 28 did not (status of the margins was unknown in 3 dogs). Twelve of 43 dogs had local recurrence. Median survival time was 694 days, and the only factor significantly associated with survival time was type of surgery performed. Median survival times were 1,188, 649, and 183 days, respectively, for dogs that underwent wide excision, marginal excision, and incisional biopsy. Factors that were not found to be significantly associated with survival time included tumor size, status of the margins, tumor location, and histologic subtype. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that in dogs, liposarcomas are locally invasive neoplasms that rarely metastasize and occur primarily in appendicular or axial locations and that wide excision is preferred to marginal excision when feasible.

Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats.

OBJECTIVE: To determine whether particular vaccine brands, other injectable medications, customary vaccination practices, or various host factors were associated with the formation of vaccine-associated sarcomas in cats. DESIGN: Prospective multicenter case-control study. ANIMALS: Cats in the United States and Canada with soft tissue sarcomas or basal cell tumors. PROCEDURE: Veterinarians submitting biopsy specimens from cats with a confirmed diagnosis of soft tissue sarcoma or basal cell tumor were contacted for patient medical history. Time window statistical analyses were used in conjunction with various assumptions about case definitions. RESULTS: No single vaccine brand or manufacturer within antigen class was found to be associated with sarcoma formation. Factors related to vaccine administration were also not associated with sarcoma development, with the possible exception of vaccine temperature prior to injection. Two injectable medications (long-acting penicillin and methyl prednisolone acetate) were administered to case cats more frequently than to control cats. CONCLUSIONS AND CLINICAL RELEVANCE: Findings do not support the hypotheses that specific brands or types of vaccine within antigen class, vaccine practices such as reuse of syringes, concomitant viral infection, history of trauma, or residence either increase or decrease the risk of vaccine-associated sarcoma formation in cats. There was evidence to suggest that certain long-acting injectable medications may also be associated with sarcoma formation.